STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 18th, 2020 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMarch 18th, 2020 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is made and entered into as of February 13, 2020, by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and John Kim Scott (the “Investor”).